Testosterone Gel: Androgel

CSR Synopses following approval of a new medicine or a new indication for an approved medicine in the US or EU. We are making CSR synopses available to supplement the public information available to patients and healthcare providers about the results of our clinical trials and the evidence used to approve a new medicine or a new indication.

{m} Entries

Study Indication or Disease
Study Name
S176.1.010 AbbVie_IU_icons_outlined_v3 Hypogonadism Phase 1 A Multiple Dose Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption after Administration of 5g Testosterone Gel 1.62% to the Upper Arms/Shoulders using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males